Prospective randomized clinical trial evaluating efficacy and safety of a new ophthalmic viscosurgical device in patients undergoing cataract surgery
- 1 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (9) , 906-911
Abstract
Purpose: To evaluate the efficacy and safety of Bio-Hyalur LVD compared with Viscoat ophthalmic viscosurgical device (OVD) in patients undergoing routine cataract surgery. Setting: 2 tertiary eyecare hospitals in Italy. Design: Prospective randomized clinical trial. Methods: This study compared the outcomes of Bio-Hyalur LVD vs Viscoat OVD in patients undergoing standard cataract surgery with phacoemulsification and intraocular lens implantation from January 2021 to April 2022. The primary outcome was mean change in IOP at 6 hours. Secondary outcomes included 1-day, 7-day, 30-day, and 90-day mean intraocular pressure (IOP); 7-day, 30-day, and 90-day corrected distance visual acuity; endothelial cell density (ECD); change in central corneal thickness (CCT); and complications including intraocular inflammation. Results: 84 eyes of 84 patients (n = 41 in the Bio-Hyalur LVD group and n = 43 in the Viscoat group) were screened, enrolled, randomized, and included in the analysis. Mean change in IOP was significantly higher in the Viscoat group than in the Bio-Hyalur LVD group 6 hours (P = .034), 7 days (P < .001), 30 days (P < .001), and 90 days (P = .003) postoperatively. Mean change in uncorrected distance visual acuity and corrected distance visual acuity was significantly higher in the Bio-Hyalur LVD group 30 and 90 days postoperatively. No significant differences in ECD, CCT, and complication rates were observed between groups at any timepoint. Conclusions: Bio-Hyalur LVD OVD was safe and effective in patients undergoing routine cataract surgery. Bio-Hyalur LVD OVD did not confer a higher risk of postoperative increase in IOP.Keywords
This publication has 10 references indexed in Scilit:
- Viscoat versus Visthesia during phacoemulsification cataract surgery: corneal and foveal changesBMC Ophthalmology, 2011
- Comparison of the effect of Viscoat and DuoVisc on postoperative intraocular pressure after small-incision cataract surgeryJournal of Cataract & Refractive Surgery, 2008
- Natural Course of Intraocular Pressure after Cataract Surgery with Sodium Chondroitin Sulfate 4%–Sodium Hyaluronate 3% (Viscoat)Ophthalmology, 2005
- Comparative evaluation of efficacy and safety of ophthalmic viscosurgical devices in phacoemulsification [ISRCTN34957881]BMC Ophthalmology, 2005
- Transient corneal edema after phacoemulsification: comparison of 3 viscoelastic regimensJournal of Cataract & Refractive Surgery, 2002
- Intraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agentsBritish Journal of Ophthalmology, 2001
- Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changesGraefe's Archive for Clinical and Experimental Ophthalmology, 2000
- Intraocular pressure after small incision cataract surgery with Healon5 and ViscoatJournal of Cataract & Refractive Surgery, 2000
- Randomized clinical comparison of Healon GV and Viscoat 1Journal of Cataract & Refractive Surgery, 1999
- Comparison of viscoelastic substances used in phacoemulsificationJournal of Cataract & Refractive Surgery, 1996